Senior insider sale
Chief Financial Officer at AARDVARK THERAPEUTICS, INC. — senior position signals high conviction
$243.7K
48.66K shares
What this filing means
SUN NELSON plans to sell 48.66K shares of AARDVARK THERAPEUTICS, INC. valued at approximately $243.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/11/2026ACC: 0001950047-26-009373
Officer· Chief Financial Officer
Since Feb 2026
48.66K
Shares to sell
$243.7K
Approx. market value
33.91K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months2
Employee Stock Purchase Plan
Cash
5/22/2026
3.75KPreviously Exercised Stock Options
Cash
9/26/2024
30.17KTotal acquired33.91K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/22/2026 | Employee Stock Purchase Plan Cash | 3.75K | — |
9/26/2024 | Previously Exercised Stock Options Cash | 30.17K | — |
| Total | 33.91K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
14.75K
Market value
$73.8K
9/10/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
33.91K
Market value
$169.9K
9/11/2026
Total
Units
48.66K
Value
$243.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/10/2026 | 14.75K | $73.8K | — | Completed |
| Planned — Approximate Date | ||||
9/11/2026 | 33.91K | $169.9K | NASDAQ | Planned |
| Total | 48.66K | $243.7K | ||